253 related articles for article (PubMed ID: 34711512)
1. The role of hormone therapy in urogenital health after menopause.
Nappi RE; Cucinella L; Martini E; Cassani C
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101595. PubMed ID: 34711512
[TBL] [Abstract][Full Text] [Related]
2. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
3. An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause.
Holton M; Thorne C; Goldstein AT
Expert Opin Pharmacother; 2020 Mar; 21(4):409-415. PubMed ID: 31928093
[No Abstract] [Full Text] [Related]
4. Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies.
Castelo-Branco C; Mension E; Torras I; Cebrecos I; Anglès-Acedo S
Climacteric; 2023 Aug; 26(4):296-301. PubMed ID: 36946290
[TBL] [Abstract][Full Text] [Related]
5. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
[TBL] [Abstract][Full Text] [Related]
6. Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.
Nappi RE; Martini E; Cucinella L; Martella S; Tiranini L; Inzoli A; Brambilla E; Bosoni D; Cassani C; Gardella B
Front Endocrinol (Lausanne); 2019; 10():561. PubMed ID: 31496993
[TBL] [Abstract][Full Text] [Related]
7. Genitourinary syndrome of menopause: the unmet need.
Spadt SK; Larkin LC
Menopause; 2021 Jan; 28(4):444-446. PubMed ID: 33752218
[TBL] [Abstract][Full Text] [Related]
8. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
Portman DJ; Gass ML;
J Sex Med; 2014 Dec; 11(12):2865-72. PubMed ID: 25155380
[TBL] [Abstract][Full Text] [Related]
9. The vagina as source and target of androgens: implications for treatment of GSM/VVA, including DHEA.
Cipriani S; Maseroli E; Ravelli SA; Vignozzi L
Climacteric; 2023 Aug; 26(4):309-315. PubMed ID: 37288964
[TBL] [Abstract][Full Text] [Related]
10. Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause.
Stute P; Bertschy S; Birkhaeuser M; Bitzer J; Ging A; Raggi A; Steimann S; Stute V
Climacteric; 2022 Jun; 25(3):246-256. PubMed ID: 34907824
[TBL] [Abstract][Full Text] [Related]
11. Different local estrogen therapies for a tailored approach to GSM.
Nappi RE; Tiranini L; Martini E; Bosoni D; Cassani C; Cucinella L
Climacteric; 2023 Aug; 26(4):361-366. PubMed ID: 37318030
[TBL] [Abstract][Full Text] [Related]
12. Genitourinary Syndrome of Menopause.
Cox S; Nasseri R; Rubin RS; Santiago-Lastra Y
Med Clin North Am; 2023 Mar; 107(2):357-369. PubMed ID: 36759102
[TBL] [Abstract][Full Text] [Related]
13. Genitourinary Syndrome of Menopause: Current Treatment Options in Breast Cancer Survivors - Systematic Review.
Mension E; Alonso I; Castelo-Branco C
Maturitas; 2021 Jan; 143():47-58. PubMed ID: 33308636
[TBL] [Abstract][Full Text] [Related]
14. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.
Faubion SS; Larkin LC; Stuenkel CA; Bachmann GA; Chism LA; Kagan R; Kaunitz AM; Krychman ML; Parish SJ; Partridge AH; Pinkerton JV; Rowen TS; Shapiro M; Simon JA; Goldfarb SB; Kingsberg SA
Menopause; 2018 Jun; 25(6):596-608. PubMed ID: 29762200
[TBL] [Abstract][Full Text] [Related]
15. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Hocké C; Diaz M; Bernard V; Frantz S; Lambert M; Mathieu C; Grellety-Cherbero M
Gynecol Obstet Fertil Senol; 2021 May; 49(5):394-413. PubMed ID: 33757926
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update.
Merlino L; D'Ovidio G; Matys V; Piccioni MG; Porpora MG; Senatori R; Viscardi MF; Vitale A; Della Rocca C; On Behalf Of Policlinico Umberto I Collaborators
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111307
[TBL] [Abstract][Full Text] [Related]
17. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study.
Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto C;
Climacteric; 2018 Apr; 21(2):167-173. PubMed ID: 29411644
[TBL] [Abstract][Full Text] [Related]
18. Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?
Biglia N; Bounous VE; Sgro LG; D'Alonzo M; Pecchio S; Nappi RE
Clin Breast Cancer; 2015 Dec; 15(6):413-20. PubMed ID: 26198332
[TBL] [Abstract][Full Text] [Related]
19. Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
Lubián López DM
World J Clin Oncol; 2022 Feb; 13(2):71-100. PubMed ID: 35316932
[TBL] [Abstract][Full Text] [Related]
20. Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review.
Jugulytė N; Žukienė G; Bartkevičienė D
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
